Yingli Luo
Wuxi, 214122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting microglial circMBNL1 unlocks a novel nanomedicine therapeutic strategy for major depressive disorder.
Journal: Journal of nanobiotechnology
Published: December 10, 2025
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury.
Journal: Cell chemical biology
Published: January 03, 2025
A Novel Oncolytic Virus Formulation Based on Mesenchymal Stem Cell-Derived Vesicles for Tumor Therapy.
Journal: Journal of Cancer
Published: September 23, 2024
Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury.
Journal: Free radical biology & medicine
Published: September 21, 2024
Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 28, 2024
Mesenchymal Stem Cell Membrane-Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal-Organic Framework Nanoparticles.
Journal: IET nanobiotechnology
Published: June 24, 2024
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases.
Journal: Science advances
Published: March 29, 2024
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron.
Journal: International immunopharmacology
Published: February 14, 2024
Tivantinib alleviates inflammatory diseases by directly targeting NLRP3.
Journal: iScience
Published: October 03, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026